Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer

NCT03440450 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy

NCT06793709 ·Status: RECRUITING

Trial of TRC105 and Sorafenib in Patients With HCC

NCT02560779 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma

NCT07239986 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma

NCT01525069 ·Status: TERMINATED ·Phase: PHASE1

A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

NCT06363825 ·Status: RECRUITING ·Phase: PHASE2

A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC

NCT01829035 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)

NCT00517920 ·Status: COMPLETED ·Phase: PHASE2

TACE Combined With Sorafenib and Tislelizumab for Advanced HCC

NCT04599777 ·Status: COMPLETED ·Phase: PHASE2

A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma

NCT03521219 ·Status: UNKNOWN ·Phase: PHASE2

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

NCT04353375 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements

NCT05174650 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)

NCT01170104 ·Status: UNKNOWN ·Phase: PHASE2

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

NCT03722498 ·Status: WITHDRAWN ·Phase: PHASE2

Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China

NCT01839630 ·Status: COMPLETED

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

NCT07201519 ·Status: RECRUITING ·Phase: PHASE2

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC

NCT05025592 ·Status: UNKNOWN

A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma

NCT00790218 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

NCT07052253 ·Status: RECRUITING ·Phase: PHASE2

Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma

NCT03738111 ·Status: WITHDRAWN ·Phase: PHASE1

A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma

NCT03586973 ·Status: COMPLETED ·Phase: PHASE2

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

NCT04601428 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma

NCT01171482 ·Status: TERMINATED ·Phase: PHASE2

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

NCT06643208 ·Status: RECRUITING

Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

NCT02557503 ·Status: UNKNOWN ·Phase: PHASE4